glaucoma

A Comprehensive Program of Glaucoma Dietary Supplements

What follows is my personal approach to glaucoma supplementation. I have arrived at this approach after decades of intense personal study (on top of my education in biochemistry).

Some of my favorite articles on FitEyes.com

Submitted by dave on Tue, 12/07/2010 - 3:03pm

FitEyes favorite articlesI think the following list represents some of the most informative and useful articles on FitEyes.com. There are thousands of articles on FitEyes.com, so many good ones will not be on this list. But this list is a good place to start reading if you are new to FitEyes.com. If you are not new to our site, please make sure you have seen these articles.

Please feel welcome to add comments to this post to mention your own favorite articles on FitEyes.com.

My experiences with self-tonometry

Submitted by Anonymous (not verified) on Tue, 05/04/2010 - 3:00pm

I have been part of FitEyes since 2006 and I bought my tonometer in late 2006. I've been using it almost every day since then. I am very calm about measuring my IOP perhaps 2 or 4 times a day (or sometimes not at all if away from home).

While away from home I use drops 'just in case'; at home I might go for several days with no drops while I monitor my IOP with my tonometer .

Oral Omega-3 Supplementation Lowers Eye Pressure

Oral Omega-3 Supplementation Lowers Intraocular Pressure in Normotensive Adults

Elevated intraocular pressure (abbreviated IOP, and also called eye pressure) is the only medically treatable risk factor for the sight-threatening eye disease, glaucoma. In this study, researchers investigated whether oral omega-3 fish oil supplements affect intraocular pressure in normotensive adults.

The conclusion of the study states, "Oral omega-3 supplementation for 3 months significantly reduced IOP in normotensive adults."

Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders Including Glaucoma

Submitted by dave on Tue, 09/25/2018 - 1:44am

A wide range of neurodegenerative diseases (NDs), including Glaucoma, Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases, share common mechanisms such as neuronal loss, apoptosis, mitochondrial dysfunction, oxidative stress, and inflammation.

Intervention strategies using plant-derived bioactive compounds have been offered as a form of treatment for these debilitating conditions, as there are currently no remedies to prevent, reverse, or halt the progression of neuronal loss. Rutin, a glycoside of the flavonoid quercetin, is found in many plants and fruits, especially buckwheat, apricots, cherries, grapes, grapefruit, plums, and oranges.

Pharmacological studies have reported the beneficial effects of rutin in many disease conditions, and its therapeutic potential in several models of NDs has created considerable excitement.

In the attached scientific paper, published in 2018, the authors summarize the current knowledge on the neuroprotective mechanisms of rutin in various experimental models of neurodegenerative diseases. The mechanisms of action reviewed in this article include reduction of proinflammatory cytokines, improved antioxidant enzyme activities, activation of the mitogen-activated protein kinase cascade, downregulation of mRNA expression of PD-linked and proapoptotic genes, upregulation of the ion transport and antiapoptotic genes, and restoration of the activities of mitochondrial complex enzymes.

Taken together, these findings suggest that rutin may be a promising neuroprotective compound for the treatment of glaucoma and other neurodegenerative diseases. Additionally, there are two studies on intraocular pressure and the combination of rutin plus forskolin (an herbal extract) which show this combination has the potential to reduce intraocular pressure.

Coleus Forskolii Extract 250 mg 60 caps by Paradise Herbs – FitEyes eStore https://estore.fiteyes.com/products/coleus-forskolii-extract-60-caps-by-...

Rutin 450 mg 100 vcaps by NOW Foods – FitEyes eStore https://estore.fiteyes.com/products/rutin-450-mg-100-vcaps-by-now-foods

Log in to download the article.

Apolipoprotein E may be associated with elevated risk of glaucoma

Submitted by dave on Sun, 09/16/2018 - 9:34pm

Apolipoprotein E is the "Alzheimer's gene". It is also widely known to be important in cardiovascular disease. Now we see it may have some bearing on glaucoma (at least in some populations). Log in to download the full text paper and read the FitEyes member-only portion of this blog post (below).

Abstract

Epidemiological studies have evaluated the association between Apolipoprotein E (APOE) gene ε2/ε3/ε4 polymorphism and glaucoma susceptibility. However, the published data are still inconclusive. The aim of the present study is to evaluate the impact of APOE gene ε2/ε3/ε4 polymorphism on glaucoma risk by using meta-analysis.

Methods

A comprehensive literature search of PubMed, EMBASE, Cochrane, Elsevier Science Direct and CNKI databases was conducted to identify relevant articles, with the last report up to January 5, 2014. Pooled odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of association by using the fixed or random effect model.

Results

Fifteen separate studies including 2,700 cases and 2,365 controls were included in the meta-analysis. We did not detect a significant association between APOE gene ε2/ε3/ε4 polymorphism and glaucoma in overall population (P > 0.0083). In Asians, we detected an association of the ε4ε4 genotype with elevated risk for glaucoma (OR = 5.22, 95% CI = 1.85-14.68, P = 0.002), mainly for primary open angle glaucoma (OR = 4.98, 95% CI = 1.75-14.20, P = 0.003).

Conclusions

The meta-analysis suggests that APOE gene ε4ε4 may be associated with elevated risk for primary open angle glaucoma in Asians. However, more epidemiologic studies based on larger sample size, case–control design and stratified by ethnicity as well as types of glaucoma are suggested to further clarify the relationship between APOE gene ε2/ε3/ε4 polymorphism and genetic predisposition to glaucoma.

Keywords: Glaucoma, APOE, Genetic, Meta-analysis

Pages

Subscribe to FitEyes.com RSS Feed Subscribe to glaucoma